| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 3.17e-05 | 2 | 113 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 2.87e-04 | 224 | 113 | 7 | GO:0016741 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 3.14e-04 | 5 | 113 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 4.17e-04 | 26 | 113 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 4.42e-04 | 172 | 113 | 6 | GO:0008757 | |
| GeneOntologyMolecularFunction | RNA methyltransferase activity | 5.66e-04 | 67 | 113 | 4 | GO:0008173 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 6.54e-04 | 7 | 113 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 8.69e-04 | 8 | 113 | 2 | GO:0043237 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 FLOT2 TRAF3IP1 NEK10 KIF21A PEX1 TACC2 CEP192 APP MAP10 DNAI3 BRCA2 SYNE2 PKD1 VPS13A CEP295 UVRAG HTT | 1.19e-05 | 1058 | 110 | 18 | GO:0007017 |
| MousePheno | increased chromosomal stability | 6.38e-06 | 6 | 97 | 3 | MP:0010095 | |
| Domain | EGF_3 | 1.40e-05 | 235 | 114 | 9 | PS50026 | |
| Domain | EGF_CA | 1.43e-05 | 86 | 114 | 6 | PF07645 | |
| Domain | EGF-like_dom | 2.21e-05 | 249 | 114 | 9 | IPR000742 | |
| Domain | EGF_1 | 2.67e-05 | 255 | 114 | 9 | PS00022 | |
| Domain | EGF_Ca-bd_CS | 2.85e-05 | 97 | 114 | 6 | IPR018097 | |
| Domain | EGF-like_CS | 3.20e-05 | 261 | 114 | 9 | IPR013032 | |
| Domain | EGF_CA | 3.20e-05 | 99 | 114 | 6 | PS01187 | |
| Domain | EGF_2 | 3.60e-05 | 265 | 114 | 9 | PS01186 | |
| Domain | ARHGEF5_35 | 3.69e-05 | 2 | 114 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 3.69e-05 | 2 | 114 | 2 | IPR029212 | |
| Domain | EGF | 9.76e-05 | 235 | 114 | 8 | SM00181 | |
| Domain | EGF_CA | 1.03e-04 | 122 | 114 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.13e-04 | 124 | 114 | 6 | IPR001881 | |
| Domain | Gal_mutarotase_N | 2.20e-04 | 4 | 114 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 2.20e-04 | 4 | 114 | 2 | PF16863 | |
| Domain | ASX_HYDROXYL | 3.68e-04 | 100 | 114 | 5 | PS00010 | |
| Domain | Growth_fac_rcpt_ | 3.92e-04 | 156 | 114 | 6 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.81e-04 | 106 | 114 | 5 | IPR000152 | |
| Domain | cEGF | 5.20e-04 | 26 | 114 | 3 | PF12662 | |
| Domain | cEGF | 5.20e-04 | 26 | 114 | 3 | IPR026823 | |
| Domain | PbH1 | 5.45e-04 | 6 | 114 | 2 | SM00710 | |
| Domain | Glyco_hydro_31_AS | 5.45e-04 | 6 | 114 | 2 | IPR030458 | |
| Domain | PbH1 | 5.45e-04 | 6 | 114 | 2 | IPR006626 | |
| Domain | Glyco_hydro_31 | 7.60e-04 | 7 | 114 | 2 | IPR000322 | |
| Domain | TB | 7.60e-04 | 7 | 114 | 2 | PF00683 | |
| Domain | Glyco_hydro_31 | 7.60e-04 | 7 | 114 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 7.60e-04 | 7 | 114 | 2 | PS00129 | |
| Domain | - | 8.46e-04 | 120 | 114 | 5 | 3.40.50.150 | |
| Domain | CH | 8.85e-04 | 70 | 114 | 4 | PF00307 | |
| Domain | SAM-dependent_MTases | 9.12e-04 | 122 | 114 | 5 | IPR029063 | |
| Domain | - | 9.34e-04 | 71 | 114 | 4 | 1.10.418.10 | |
| Domain | - | 1.01e-03 | 8 | 114 | 2 | 3.90.290.10 | |
| Domain | Pectin_lyase_fold/virulence | 1.01e-03 | 8 | 114 | 2 | IPR011050 | |
| Domain | Trefoil | 1.01e-03 | 8 | 114 | 2 | PF00088 | |
| Domain | CH | 1.04e-03 | 73 | 114 | 4 | PS50021 | |
| Domain | EGF | 1.05e-03 | 126 | 114 | 5 | PF00008 | |
| Domain | CH-domain | 1.15e-03 | 75 | 114 | 4 | IPR001715 | |
| Domain | P_TREFOIL_2 | 1.29e-03 | 9 | 114 | 2 | PS51448 | |
| Domain | TB_dom | 1.29e-03 | 9 | 114 | 2 | IPR017878 | |
| Domain | TB | 1.29e-03 | 9 | 114 | 2 | PS51364 | |
| Domain | PD | 1.29e-03 | 9 | 114 | 2 | SM00018 | |
| Domain | MAC_perforin | 1.61e-03 | 10 | 114 | 2 | IPR001862 | |
| Domain | - | 1.96e-03 | 11 | 114 | 2 | 4.10.110.10 | |
| Domain | MACPF | 1.96e-03 | 11 | 114 | 2 | PF01823 | |
| Domain | P_trefoil_dom | 2.34e-03 | 12 | 114 | 2 | IPR000519 | |
| Domain | MACPF | 2.34e-03 | 12 | 114 | 2 | IPR020864 | |
| Domain | MACPF | 2.34e-03 | 12 | 114 | 2 | SM00457 | |
| Domain | Gal_mutarotase_SF_dom | 4.73e-03 | 17 | 114 | 2 | IPR011013 | |
| Domain | SCAN_BOX | 5.35e-03 | 58 | 114 | 3 | PS50804 | |
| Domain | SCAN | 5.35e-03 | 58 | 114 | 3 | PF02023 | |
| Domain | SCAN_dom | 5.35e-03 | 58 | 114 | 3 | IPR003309 | |
| Domain | Retrov_capsid_C | 5.62e-03 | 59 | 114 | 3 | IPR008916 | |
| Domain | BRCT | 5.90e-03 | 19 | 114 | 2 | PF00533 | |
| Pubmed | Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis. | 1.44e-07 | 4 | 116 | 3 | 31155506 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 27732952 | ||
| Pubmed | Dnmt2-null sperm block maternal transmission of a paramutant phenotype†. | 1.10e-05 | 2 | 116 | 2 | 33929014 | |
| Pubmed | [Influence of temperature on spermatogenesis-related genes in spermatogonia cultured in vitro]. | 1.10e-05 | 2 | 116 | 2 | 22568210 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30803762 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21305033 | ||
| Pubmed | Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. | 1.10e-05 | 2 | 116 | 2 | 22197298 | |
| Pubmed | Circadian and Brain State Modulation of Network Hyperexcitability in Alzheimer's Disease. | 1.10e-05 | 2 | 116 | 2 | 29780880 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 28550267 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17548355 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 36901941 | ||
| Pubmed | Tooth loss induces memory impairment and neuronal cell loss in APP transgenic mice. | 1.10e-05 | 2 | 116 | 2 | 23773908 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 38600586 | ||
| Pubmed | Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin. | 1.10e-05 | 2 | 116 | 2 | 32452382 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 16210396 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22049429 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 28004443 | ||
| Pubmed | A potential function for neuronal exosomes: sequestering intracerebral amyloid-β peptide. | 1.10e-05 | 2 | 116 | 2 | 25436414 | |
| Pubmed | Somatic APP gene recombination in Alzheimer's disease and normal neurons. | 1.10e-05 | 2 | 116 | 2 | 30464338 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 28487416 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 35697511 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 39040546 | ||
| Pubmed | RNA-mediated epigenetic heredity requires the cytosine methyltransferase Dnmt2. | 1.10e-05 | 2 | 116 | 2 | 23717211 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 10818140 | ||
| Pubmed | Istradefylline reduces memory deficits in aging mice with amyloid pathology. | 1.10e-05 | 2 | 116 | 2 | 29100987 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19542222 | ||
| Pubmed | Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. | 1.10e-05 | 2 | 116 | 2 | 23776240 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 39043843 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19101630 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23560052 | ||
| Pubmed | Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro. | 1.10e-05 | 2 | 116 | 2 | 11376898 | |
| Pubmed | Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole. | 1.10e-05 | 2 | 116 | 2 | 27562453 | |
| Pubmed | UBR1 COL6A2 ARHGEF5 PEX1 SRPK1 BTAF1 TRMT2A SUPV3L1 SHCBP1 CMTR2 GARRE1 | 1.19e-05 | 650 | 116 | 11 | 38777146 | |
| Pubmed | COL6A2 MBTD1 ANK2 BACH2 TACC2 SNX19 FREM1 EHMT2 SHCBP1 PKD1 VPS13A NID1 KIT UTRN TRDMT1 | 1.31e-05 | 1215 | 116 | 15 | 15146197 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.47e-05 | 430 | 116 | 9 | 35044719 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21088218 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17161064 | ||
| Pubmed | Cloning of mouse ojoplano, a reticular cytoplasmic protein expressed during embryonic development. | 3.30e-05 | 3 | 116 | 2 | 19766735 | |
| Pubmed | Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). | 3.30e-05 | 3 | 116 | 2 | 7730318 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10353238 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 29737568 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37575021 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 32921309 | ||
| Pubmed | Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage. | 3.30e-05 | 3 | 116 | 2 | 24291464 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17360894 | ||
| Pubmed | Overlapping and differential functions of ATF6α versus ATF6β in the mouse heart. | 3.30e-05 | 3 | 116 | 2 | 30765833 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 16549802 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19122666 | ||
| Pubmed | Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. | 3.30e-05 | 3 | 116 | 2 | 23748737 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27447728 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 34477811 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18672106 | ||
| Pubmed | MT1-MMP targeting to endolysosomes is mediated by upregulation of flotillins. | 3.30e-05 | 3 | 116 | 2 | 30111578 | |
| Pubmed | Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice. | 3.30e-05 | 3 | 116 | 2 | 20952415 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28205565 | ||
| Pubmed | Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. | 3.30e-05 | 3 | 116 | 2 | 7520444 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19901339 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17785178 | ||
| Pubmed | Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration. | 3.30e-05 | 3 | 116 | 2 | 22361682 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 34609281 | ||
| Pubmed | Changes in protein expression due to deleterious mutations in the FA/BRCA pathway. | 3.30e-05 | 3 | 116 | 2 | 17977515 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24465508 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28346227 | ||
| Pubmed | Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice. | 3.30e-05 | 3 | 116 | 2 | 25673831 | |
| Pubmed | PIK3CG Regulates NLRP3/GSDMD-Mediated Pyroptosis in Septic Myocardial Injury. | 3.30e-05 | 3 | 116 | 2 | 37676465 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10743502 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZBTB20 ACTR3C EVC BTAF1 CEP192 ACVR2B APP SLC35F5 CCNG2 USF3 SPACA6 NRG3 KAT6B UTRN HTT PDZD2 | 3.60e-05 | 1489 | 116 | 16 | 28611215 |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 15611103 | ||
| Pubmed | Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. | 6.59e-05 | 4 | 116 | 2 | 21113149 | |
| Pubmed | Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ1-42 synaptotoxicity. | 6.59e-05 | 4 | 116 | 2 | 28877993 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 22316281 | ||
| Pubmed | Phenotyping structural abnormalities in mouse embryos using high-resolution episcopic microscopy. | 6.59e-05 | 4 | 116 | 2 | 25256713 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 21795680 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 6.59e-05 | 4 | 116 | 2 | 11104663 | |
| Pubmed | Common variations in 4p locus are related to male completed suicide. | 6.59e-05 | 4 | 116 | 2 | 19115052 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 18806802 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 20861915 | ||
| Pubmed | FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease. | 6.59e-05 | 4 | 116 | 2 | 23921129 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 33691783 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 22819042 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 21931569 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 16157329 | ||
| Pubmed | 9.02e-05 | 313 | 116 | 7 | 20800603 | ||
| Pubmed | FLOT2 MBTD1 BACH2 PEX1 APP NELL2 TRMT2A EHMT2 SCN5A PNMA2 CEP295 KAT6B GARRE1 | 9.25e-05 | 1116 | 116 | 13 | 31753913 | |
| Pubmed | 9.47e-05 | 218 | 116 | 6 | 19460752 | ||
| Pubmed | ANK2 TRAF3IP1 KIF21A FTCD APP NELL2 EHMT2 TRIM9 SUPV3L1 PKD1 PNMA2 LTBP3 MORC3 UTRN | 9.95e-05 | 1285 | 116 | 14 | 35914814 | |
| Pubmed | Identification of 15 loci influencing height in a Korean population. | 9.97e-05 | 27 | 116 | 3 | 19893584 | |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 19897194 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 15851119 | ||
| Pubmed | A small secreted protein NICOL regulates lumicrine-mediated sperm maturation and male fertility. | 1.10e-04 | 5 | 116 | 2 | 37095084 | |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 24870542 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 7961179 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 12970790 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 23038782 | ||
| Pubmed | NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. | 1.10e-04 | 5 | 116 | 2 | 32499443 | |
| Pubmed | Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth. | 1.10e-04 | 5 | 116 | 2 | 22782894 | |
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 38352874 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 18025271 | ||
| Pubmed | 1.10e-04 | 5 | 116 | 2 | 17596926 | ||
| Cytoband | 10q22-q23 | 6.30e-05 | 5 | 116 | 2 | 10q22-q23 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 8.82e-05 | 4 | 70 | 2 | 628 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 2.31e-05 | 38 | 115 | 4 | M1751 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZBTB20 NUP98 BTAF1 APP ZNF804A MDN1 BRCA2 BAZ1A DBF4 SYNE2 VPS13A KAT6B UVRAG GARRE1 | 2.37e-05 | 856 | 115 | 14 | M4500 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 2.84e-05 | 40 | 115 | 4 | MM17488 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 2.87e-05 | 199 | 115 | 7 | M3132 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 3.46e-05 | 42 | 115 | 4 | MM733 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_UP | 4.60e-05 | 146 | 115 | 6 | M12275 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ZBTB20 ANK2 KIF21A BTAF1 ACVR2B NELL2 MDN1 BRCA2 BAZ1A DBF4 SYNE2 VPS13A SPACA6 RGS17 KAT6B TGS1 PHACTR1 | 1.53e-05 | 983 | 112 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ANK2 TRAF3IP1 BACH2 KIF21A BTAF1 CEP192 ACVR2B MDN1 BRCA2 BAZ1A DBF4 SUPV3L1 MDC1 SYNE2 VPS13A SPACA6 CEP295 CPLANE1 TGS1 | 2.99e-05 | 1257 | 112 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.05e-05 | 311 | 112 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZBTB20 KIF21A EVC BTAF1 BAZ1A TRIM9 DBF4 SYNE2 VPS13A RGS17 KAT6B TGS1 PHACTR1 | 4.13e-05 | 654 | 112 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.11e-05 | 328 | 112 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ZBTB20 TRAF3IP1 KIF21A NELL2 BRCA2 BAZ1A TRIM9 SYNE2 CEP295 KIT TGS1 | 6.58e-05 | 498 | 112 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.21e-05 | 192 | 112 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | COL6A2 NIBAN1 TRAF3IP1 BACH2 EVC FREM1 BRCA2 NFATC4 BAZ1A SPACA6 NID1 TGS1 | 8.74e-05 | 607 | 112 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.74e-09 | 189 | 116 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-09 | 189 | 116 | 9 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-09 | 189 | 116 | 9 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-09 | 189 | 116 | 9 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.29e-09 | 195 | 116 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.29e-09 | 195 | 116 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-08 | 185 | 116 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.32e-08 | 187 | 116 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.76e-08 | 190 | 116 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.91e-08 | 191 | 116 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 4.07e-08 | 192 | 116 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.24e-08 | 193 | 116 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.41e-08 | 194 | 116 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.41e-08 | 194 | 116 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.84e-07 | 167 | 116 | 7 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.89e-07 | 181 | 116 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.47e-07 | 184 | 116 | 7 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.67e-07 | 185 | 116 | 7 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.88e-07 | 186 | 116 | 7 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.88e-07 | 186 | 116 | 7 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.54e-07 | 189 | 116 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.78e-07 | 190 | 116 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.02e-07 | 191 | 116 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.02e-07 | 191 | 116 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-07 | 194 | 116 | 7 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-07 | 194 | 116 | 7 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-07 | 194 | 116 | 7 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-07 | 194 | 116 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-07 | 194 | 116 | 7 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-07 | 195 | 116 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 8.64e-07 | 197 | 116 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 8.64e-07 | 197 | 116 | 7 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 8.94e-07 | 198 | 116 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 116 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.56e-07 | 200 | 116 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.56e-07 | 200 | 116 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.56e-07 | 200 | 116 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.56e-07 | 200 | 116 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 167 | 116 | 6 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-06 | 172 | 116 | 6 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.40e-06 | 174 | 116 | 6 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-06 | 103 | 116 | 5 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 7.77e-06 | 180 | 116 | 6 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 8.02e-06 | 181 | 116 | 6 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.02e-06 | 181 | 116 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.28e-06 | 182 | 116 | 6 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|World / Lineage and Cell class | 8.28e-06 | 182 | 116 | 6 | a7e7aa10f14111a6c7ba22e0f1668dcaa124714d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.54e-06 | 183 | 116 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.54e-06 | 183 | 116 | 6 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.81e-06 | 184 | 116 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.81e-06 | 184 | 116 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.09e-06 | 185 | 116 | 6 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.96e-06 | 188 | 116 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 189 | 116 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.06e-05 | 190 | 116 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.06e-05 | 190 | 116 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 191 | 116 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 191 | 116 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 191 | 116 | 6 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 191 | 116 | 6 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Otof_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.11e-05 | 53 | 116 | 4 | a41f66edf468f824494a922c3addf429a9125b7f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 192 | 116 | 6 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.12e-05 | 192 | 116 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 192 | 116 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 192 | 116 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-05 | 192 | 116 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 192 | 116 | 6 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 192 | 116 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-05 | 193 | 116 | 6 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-05 | 193 | 116 | 6 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 194 | 116 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.23e-05 | 195 | 116 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 196 | 116 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 196 | 116 | 6 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 196 | 116 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-05 | 196 | 116 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 196 | 116 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 196 | 116 | 6 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 197 | 116 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-05 | 197 | 116 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-05 | 197 | 116 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.38e-05 | 199 | 116 | 6 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.38e-05 | 199 | 116 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 199 | 116 | 6 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 199 | 116 | 6 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.38e-05 | 199 | 116 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.38e-05 | 199 | 116 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 200 | 116 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-05 | 200 | 116 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 200 | 116 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | 5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 200 | 116 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.41e-05 | 200 | 116 | 6 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 200 | 116 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| Computational | Genes in the cancer module 349. | 1.35e-04 | 17 | 65 | 3 | MODULE_349 | |
| Disease | body weight | MGAM GTF2A1L BRINP1 CEP192 USF3 NUDT3 NFATC4 SPHKAP PKD1 LTBP1 LTBP3 KAT6B KIT PDZD2 PHACTR1 | 5.61e-05 | 1261 | 108 | 15 | EFO_0004338 |
| Disease | sick sinus syndrome (is_implicated_in) | 1.32e-04 | 5 | 108 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | long QT syndrome (is_implicated_in) | 2.75e-04 | 7 | 108 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | cholesteryl ester 16:2 measurement | 2.75e-04 | 7 | 108 | 2 | EFO_0021435 | |
| Disease | hemoglobin A1 measurement | 6.65e-04 | 520 | 108 | 8 | EFO_0007629 | |
| Disease | Amelogenesis Imperfecta | 8.55e-04 | 12 | 108 | 2 | C0002452 | |
| Disease | male infertility (implicated_via_orthology) | 1.01e-03 | 13 | 108 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Genetic chronic primary adrenal insufficiency | 1.01e-03 | 13 | 108 | 2 | Orphanet_101960 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.17e-03 | 125 | 108 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.17e-03 | 125 | 108 | 4 | C1879321 | |
| Disease | sulfate measurement | 1.17e-03 | 14 | 108 | 2 | EFO_0007864 | |
| Disease | bilirubin measurement | 1.23e-03 | 442 | 108 | 7 | EFO_0004570 | |
| Disease | bipolar disorder | 1.30e-03 | 577 | 108 | 8 | MONDO_0004985 | |
| Disease | Romano-Ward Syndrome | 1.54e-03 | 16 | 108 | 2 | C0035828 | |
| Disease | colorectal mucinous adenocarcinoma | 1.54e-03 | 16 | 108 | 2 | EFO_0009361 | |
| Disease | sphingomyelin 14:0 measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0010390 | |
| Disease | cervical artery dissection | 1.74e-03 | 17 | 108 | 2 | EFO_1000059 | |
| Disease | lateral occipital cortex volume measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0010311 | |
| Disease | Malignant neoplasm of breast | EREG ANK2 RASGRF2 NUP98 TACC2 ADRA1A TRMT2A BRCA2 SYNE2 KAT6B KIT | 1.95e-03 | 1074 | 108 | 11 | C0006142 |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 1.95e-03 | 18 | 108 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | urate measurement, bone density | 2.01e-03 | 619 | 108 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.74e-03 | 801 | 108 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Mood Disorders | 3.43e-03 | 168 | 108 | 4 | C0525045 | |
| Disease | Neoplasm of the genitourinary tract | 3.48e-03 | 24 | 108 | 2 | cv:C0042065 | |
| Disease | Brugada Syndrome (disorder) | 3.48e-03 | 24 | 108 | 2 | C1142166 | |
| Disease | amino acid measurement | 3.51e-03 | 678 | 108 | 8 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVEVPESRNVTDCCE | 81 | Q5DID0 | |
| LEPRSQTVTVDFCQE | 811 | Q9BYV9 | |
| CEPQNVDSERSEQFI | 461 | O60477 | |
| ESVEEVVREVCSEQA | 281 | P05067 | |
| RQPAPEDETICQINE | 166 | P35348 | |
| VEPNQESLVAEACDT | 86 | Q12774 | |
| TQVEQCEPVNDAVRR | 76 | P54840 | |
| TLQPRCEDVETAEGV | 51 | Q14254 | |
| QSEAVLQEPQDCAAV | 101 | A6NE02 | |
| TCNPSTREQICEVEE | 51 | P47895 | |
| VEPNQESLVAEACDT | 86 | A5YM69 | |
| RIVEEDCNIPSTHDV | 111 | Q16589 | |
| ERLEGCESSQPQVEE | 286 | A6NC57 | |
| SLTECLQDEQVVVPS | 561 | Q8IYT2 | |
| CGEDASEAQEVTIPR | 536 | Q96KQ7 | |
| IFNCRIDEDVTDEQP | 51 | Q8IWG1 | |
| EFITQEENRICSSPV | 601 | Q9UBU7 | |
| QINCVTREPLTADEE | 761 | Q9NRL2 | |
| VLEECQNPTAEEVLS | 66 | Q9UGC6 | |
| QEENRREETCAPVSP | 1321 | Q8WYB5 | |
| LVIVESADNQPETCE | 3846 | Q01484 | |
| VSIPVSDCLIAEQQE | 636 | P56975 | |
| AVEAVVECNSRLNPI | 266 | Q9UGV2 | |
| CVIAEEQNSQTPLRD | 1476 | P52948 | |
| ALQQEQRITDCAVEP | 631 | Q8TDR0 | |
| CEQAPEEVSEARREN | 521 | Q9NU22 | |
| SPCVFQQDAVVDRIV | 646 | Q9P2G4 | |
| ETEQSSESLRCNVEP | 16 | Q14676 | |
| VTDPCQADTIRNDIT | 756 | Q99435 | |
| DISENVRVEVPNTDC | 171 | Q05BQ5 | |
| IPQSERIDCTPDQEV | 46 | Q2M2H8 | |
| TEQRCSASVLPVDVQ | 446 | P10721 | |
| NRILCSEVDPEVNSN | 1151 | A6NM62 | |
| SISDVVDEVIQNCPI | 166 | Q9C0K3 | |
| VTPNVEVNVECRINA | 251 | P14415 | |
| VSAECPVVNELERIN | 86 | O43451 | |
| EENQCIAPVVSSRVS | 16 | Q8WYA1 | |
| VCINNEVVEPSAEQI | 81 | P50135 | |
| VQVCEDPETSVEIRI | 316 | Q6ZWH5 | |
| CIRPAESNEQIEETD | 1506 | Q14766 | |
| VRNDAVILPSCVEAE | 661 | Q14149 | |
| EEEPSVAAVREVCEE | 56 | O95989 | |
| PSESEEEQIEICSTR | 1591 | O15018 | |
| DEGTCVAVVDQRPIN | 746 | P14543 | |
| DEAPDFVVQNITVCE | 1146 | Q5H8C1 | |
| VQADNPSISVEECLE | 221 | Q9UL42 | |
| EIRQVPTVVIECDDN | 361 | Q9C0D0 | |
| EINPRQCATEVSRED | 101 | Q8IZS5 | |
| TLECQVAEVETGEQR | 216 | Q9Y3R4 | |
| TQSDPQEPREENCTI | 306 | Q5K4E3 | |
| AAETSQRIQEEECPP | 201 | Q9NV92 | |
| CTVVVDVTDINDNRP | 331 | Q9Y5E2 | |
| CQSPRITFEPQDVEV | 231 | A1KZ92 | |
| ICENIVAQSVRNSPE | 106 | P42858 | |
| PQTVNEDICVEELVT | 1801 | P51587 | |
| DEVVAPVRETCAQTL | 361 | O14981 | |
| EECPVDVETCSNQQI | 166 | Q86V35 | |
| EFTEEVQCQREEPLE | 1941 | Q9H799 | |
| SRDDFPVTEVLNQVC | 386 | O15063 | |
| ELSVAQCTQRPVDIV | 821 | P12110 | |
| QEEETVNCQGPRDTA | 71 | Q8N1P7 | |
| EIAPTQVTETDECRL | 566 | Q9NS15 | |
| PVSCQEPIDEDQRIS | 1186 | Q8TEP8 | |
| EEENVRATEAVVALC | 506 | P57679 | |
| DNCTALVQTEDNPRV | 46 | O14944 | |
| TCRVLDINPQVEETD | 2306 | Q9C0D2 | |
| DINPQVEETDSRLCV | 2311 | Q9C0D2 | |
| LDCPVQDVTVTRGDQ | 151 | W5XKT8 | |
| FCADQPRIVDEEAIV | 206 | Q6ZTR5 | |
| VSCQQVEVEPLSADD | 101 | O43933 | |
| RRGCEEEDVATQQPV | 71 | Q5SV97 | |
| EVEDCVTNRPCRSQV | 106 | P07358 | |
| EETCREAQELSLPVV | 251 | O95954 | |
| EEQQVRVVQPEAATC | 141 | P98161 | |
| QATVTVQVLACREPE | 2136 | P98161 | |
| RNIQEPTETCFEEAQ | 111 | O14921 | |
| VREDVDVIECSLQFP | 201 | P41145 | |
| VSNPTVICQEDSIEE | 101 | Q96P20 | |
| ECEEEAINIQSTAPE | 276 | P46939 | |
| PVDSAVAVECDEQVL | 656 | Q9P2Y5 | |
| VPLIQIETDQREACA | 1426 | Q2M3C7 | |
| ELCPEAVEDARVNAQ | 461 | Q8IZ69 | |
| RESCIPAQVVAAIDV | 21 | O14717 | |
| RIQRVPEDSEQCESL | 496 | Q8WV83 | |
| TIVPAEIESQVEECR | 3651 | Q8WXH0 | |
| EAQELDVCRSVQPTS | 91 | Q8NDG6 | |
| ECSQRSAQELPQVEA | 576 | Q14934 | |
| TVEENVDNPRVDLCN | 801 | O14827 | |
| CVPIAVAESDTDDQE | 1046 | Q14524 | |
| RTDPSEQVEGNCEIV | 601 | Q8NEM2 | |
| QESIRAEIPCEDEQE | 446 | Q96SB4 | |
| CDLVTGEERVTVQPN | 251 | Q8IYB8 | |
| PTTNICVFADEQVDR | 256 | Q96EM0 | |
| VAEEQTQLFRCPEQD | 41 | Q99941 | |
| DRQECVATEENPQVY | 86 | Q13705 | |
| IPESQSEQDFVLRVC | 261 | P48736 | |
| DFDQDQVIDRIDVCP | 706 | P35443 | |
| QVIDRIDVCPENAEV | 711 | P35443 | |
| ENVDADTPSACVVER | 261 | P0CG00 | |
| INPLDETVSQRCIIE | 571 | Q96RL7 | |
| ETVSQRCIIEAEPLE | 576 | Q96RL7 | |
| TNAIEVVREICISEP | 881 | Q9BX84 | |
| DNCEESEVSEREAQP | 761 | Q9BZQ8 | |
| DVPDLFDTDNVIVCQ | 426 | Q9UNN4 | |
| QTRVCPQIDADNATD | 236 | Q7Z4S6 | |
| QVVPSEEDEANVRAV | 11 | Q5VZP5 | |
| NVDADTPSACVVERE | 266 | Q9BUG6 | |
| ENSRCPLNEEVIVQA | 176 | Q8IWV7 | |
| VEIIAEPCRVEQDSS | 976 | Q68DE3 | |
| APETEACDETQEGRQ | 1076 | O95359 | |
| ECETSPAAQQLVDVD | 1711 | Q86WI1 | |
| PAQEQDCVVVITREV | 1081 | Q86YV5 | |
| CAIPEIANSEEVQEF | 641 | Q92543 | |
| IDECTRIVSQNVGDV | 186 | Q9HC78 | |
| QACARNILVQTPESE | 31 | Q9C026 | |
| KEATQRPCEDQEVRT | 266 | Q5QJ38 | |
| DCVTQEVPDSRQAET | 601 | Q96RS0 | |
| VVEQEVCASVPEIAA | 136 | Q6ZRP0 | |
| NVDADTPSACVVERE | 266 | A6NGD5 | |
| CEVPEREEQEQQAEV | 156 | P53814 | |
| ENCNEISQRVVVDSV | 146 | Q7Z570 |